112 related articles for article (PubMed ID: 28069036)
21. Immunohistochemical Analysis of the Expression of Adhesion Proteins: TNS1, TNS2 and TNS3 in Correlation with Clinicopathological Parameters in Gastric Cancer.
Nizioł M; Zińczuk J; Zaręba K; Guzińska-Ustymowicz K; Pryczynicz A
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33926026
[TBL] [Abstract][Full Text] [Related]
22. C5b-9 Staining Correlates With Clinical and Tumor Stage in Gastric Adenocarcinoma.
Chen J; Yang WJ; Sun HJ; Yang X; Wu YZ
Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):470-5. PubMed ID: 26186252
[TBL] [Abstract][Full Text] [Related]
23. Cytoplasmic CCR7 (CCR7c) Immunoexpression Is Associated with Tumor Invasion in Gastric Cancer.
Vahedi L; Sheidaei S; Ghasemi M; Ebrahimi K; Yazdani Cherati J
Int J Hematol Oncol Stem Cell Res; 2023 Oct; 17(4):267-274. PubMed ID: 38076780
[No Abstract] [Full Text] [Related]
24. Prognostic significance of TPX2 and NIBP in esophageal cancer.
Sui C; Song Z; Yu H; Wang H
Oncol Lett; 2019 Oct; 18(4):4221-4229. PubMed ID: 31516617
[TBL] [Abstract][Full Text] [Related]
25. Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib.
Ge W; Wang Y; Quan M; Mao T; Bischof EY; Xu H; Zhang X; Li S; Yue M; Ma J; Yang H; Wang L; Yu Z; Wang L; Cui J
Mol Cancer; 2024 Mar; 23(1):48. PubMed ID: 38459558
[TBL] [Abstract][Full Text] [Related]
26. Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors.
Zhu M; Wang X; Zhang Q; Xie C; Wang T; Shen K; Zhang L; Zhou X
Aging (Albany NY); 2024 Feb; 16(3):2563-2590. PubMed ID: 38315450
[TBL] [Abstract][Full Text] [Related]
27. Identification of GNG7 as a novel biomarker and potential therapeutic target for gastric cancer via bioinformatic analysis and
Duan H; Chen B; Wang W; Luo H
Aging (Albany NY); 2023 Feb; 15(5):1445-1474. PubMed ID: 36863706
[TBL] [Abstract][Full Text] [Related]
28. TPX2 promotes ovarian tumorigenesis by interacting with Lamin A/C and affecting its stability.
Meng X; Cao J; Zheng H; Ma X; Wang Y; Tong Y; Xie S; Lu R; Guo L
Cancer Med; 2023 Apr; 12(8):9738-9748. PubMed ID: 36789877
[TBL] [Abstract][Full Text] [Related]
29. LncRNA KCNQ1OT1 enhances the radioresistance of lung squamous cell carcinoma by targeting the miR-491-5p/TPX2-RNF2 axis.
Liu J; Jiang M; Guan J; Wang Y; Yu W; Hu Y; Zhang X; Yang J
J Thorac Dis; 2022 Oct; 14(10):4081-4095. PubMed ID: 36389338
[TBL] [Abstract][Full Text] [Related]
30. Common Core Genes Play Vital Roles in Gastric Cancer With Different Stages.
Yu Z; Liang C; Tu H; Qiu S; Dong X; Zhang Y; Ma C; Li P
Front Genet; 2022; 13():881948. PubMed ID: 35938042
[No Abstract] [Full Text] [Related]
31. Suppression of histone deacetylase 1 by JSL-1 attenuates the progression and metastasis of cholangiocarcinoma via the TPX2/Snail axis.
Xu L; Yang W; Che J; Li D; Wang H; Li Y; Zhou W
Cell Death Dis; 2022 Apr; 13(4):324. PubMed ID: 35395834
[TBL] [Abstract][Full Text] [Related]
32. TPX2 is a prognostic marker and promotes cell proliferation in neuroblastoma.
Koike Y; Yin C; Sato Y; Nagano Y; Yamamoto A; Kitajima T; Shimura T; Kawamura M; Matsushita K; Okugawa Y; Amano K; Otake K; Okita Y; Ohi M; Inoue M; Uchida K; Hirayama M; Toiyama Y
Oncol Lett; 2022 Apr; 23(4):136. PubMed ID: 35317024
[TBL] [Abstract][Full Text] [Related]
33. Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis.
Wang L; Hou S; Li J; Tian T; Hu R; Yu N
Bioengineered; 2022 Jan; 13(1):1209-1223. PubMed ID: 34982022
[TBL] [Abstract][Full Text] [Related]
34. Identification of novel antioxidant gene signature to predict the prognosis of patients with gastric cancer.
Wu J; Wang X; Wang N; Ma L; Xie X; Zhang H; Kang H; Zhou Z
World J Surg Oncol; 2021 Jul; 19(1):219. PubMed ID: 34284774
[TBL] [Abstract][Full Text] [Related]
35. Competing Endogenous RNA Networks in Glioma.
Cen L; Liu R; Liu W; Li Q; Cui H
Front Genet; 2021; 12():675498. PubMed ID: 33995499
[TBL] [Abstract][Full Text] [Related]
36. Key Genes and Prognostic Analysis in HER2+ Breast Cancer.
Weng Y; Liang W; Ji Y; Li Z; Jia R; Liang Y; Ning P; Xu Y
Technol Cancer Res Treat; 2021; 20():1533033820983298. PubMed ID: 33499770
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of TPX2 predicts poor clinical outcome and is associated with immune infiltration in hepatic cell cancer.
Zhu H; Liu J; Feng J; Zhang Q; Bian T; Li X; Sun H; Zhang J; Liu Y
Medicine (Baltimore); 2020 Dec; 99(49):e23554. PubMed ID: 33285774
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Prediction Using a Stemness Index-Related Signature in a Cohort of Gastric Cancer.
Chen X; Zhang D; Jiang F; Shen Y; Li X; Hu X; Wei P; Shen X
Front Mol Biosci; 2020; 7():570702. PubMed ID: 33134315
[TBL] [Abstract][Full Text] [Related]
39. CircPOSTN/miR-361-5p/TPX2 axis regulates cell growth, apoptosis and aerobic glycolysis in glioma cells.
Long N; Chu L; Jia J; Peng S; Gao Y; Yang H; Yang Y; Zhao Y; Liu J
Cancer Cell Int; 2020; 20():374. PubMed ID: 32774168
[TBL] [Abstract][Full Text] [Related]
40. Cell division cycle proteinising prognostic biomarker of breast cancer.
Cheng L; Huang YZ; Chen WX; Shi L; Li Z; Zhang X; Dai XY; Wei JF; Ding Q
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32285914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
